What is the price-to-earnings ratio of Jiangsu Yahong Meditech Co?
The price-earnings ratio of Jiangsu Yahong Meditech Co is currently 16.36.
Jiangsu Yahong Meditech Co's Price to Sales (P/S) Ratio is a crucial financial metric that measures the company's market valuation relative to its total sales revenue. It's calculated by dividing the company's market capitalization by its total sales over a specific period. A lower P/S ratio can indicate that the company is undervalued, while a higher ratio may suggest overvaluation.
Comparing Jiangsu Yahong Meditech Co's P/S ratio yearly provides insights into how the market perceives the company’s value relative to its sales. An increasing ratio over time can indicate growing investor confidence, while a decreasing trend might reflect concerns about the company’s revenue generation capabilities or market conditions.
The P/S ratio is instrumental for investors evaluating Jiangsu Yahong Meditech Co's stock. It offers insights into the company’s efficiency in generating sales and its market valuation. Investors use this ratio to compare similar companies within the same industry, aiding in selecting stocks that offer the best value for investment.
Variations in Jiangsu Yahong Meditech Co’s P/S ratio can result from changes in the stock price, sales revenue, or both. Understanding these fluctuations is crucial for investors to evaluate the company’s current valuation and future growth potential, aligning their investment strategies accordingly.
The price-earnings ratio of Jiangsu Yahong Meditech Co is currently 16.36.
The price-to-earnings ratio of Jiangsu Yahong Meditech Co has increased by 0% fallen (meaning "decreased" or "dropped") compared to last year.
A high price-to-earnings ratio indicates that the company's stock is relatively expensive and investors may potentially achieve a lower return.
A low price-earnings ratio means that the company's stock is relatively cheap and investors may potentially achieve a higher return.
Yes, the price-to-earnings ratio of Jiangsu Yahong Meditech Co is high compared to other companies.
An increase in the price-earnings ratio of Jiangsu Yahong Meditech Co would lead to a higher market capitalization of the company, which in turn would lead to a higher valuation of the company.
A decrease in the price-earnings ratio of Jiangsu Yahong Meditech Co would result in a lower market capitalization of the company, which in turn would lead to a lower valuation of the company.
Some factors that influence the price-earnings ratio of Jiangsu Yahong Meditech Co are the company's growth, financial position, industry development, and the overall economic situation.
Over the past 12 months, Jiangsu Yahong Meditech Co paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Jiangsu Yahong Meditech Co is expected to pay a dividend of 0 CNY.
The current dividend yield of Jiangsu Yahong Meditech Co is .
Jiangsu Yahong Meditech Co pays a quarterly dividend. This is distributed in the months of .
Jiangsu Yahong Meditech Co paid dividends every year for the past 0 years.
For the upcoming 12 months, dividends amounting to 0 CNY are expected. This corresponds to a dividend yield of 0 %.
Jiangsu Yahong Meditech Co is assigned to the 'Health' sector.
To receive the latest dividend of Jiangsu Yahong Meditech Co from 11/1/2024 amounting to 0 CNY, you needed to have the stock in your portfolio before the ex-date on 11/1/2024.
The last dividend was paid out on 11/1/2024.
In the year 2023, Jiangsu Yahong Meditech Co distributed 0 CNY as dividends.
The dividends of Jiangsu Yahong Meditech Co are distributed in CNY.
Our stock analysis for Jiangsu Yahong Meditech Co Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Jiangsu Yahong Meditech Co Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.